JCM Free Medline Searching
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.01391-06v1
44/12/4486    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Bai, F.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Bai, F.-Y.
Journal of Clinical Microbiology, December 2006, p. 4486-4490, Vol. 44, No. 12
0095-1137/06/$08.00+0     doi:10.1128/JCM.01391-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Candida pseudorugosa sp. nov., a Novel Yeast Species from Sputum{triangledown}

Juan Li,1,3 Ying-Chun Xu,2 and Feng-Yan Bai1*

Systematic Mycology and Lichenology Laboratory, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100080, China,1 Peking Union Medical College Hospital, Beijing 100730, China,2 Graduate School of the Chinese Academy of Sciences, Beijing 100039, China3

Received 6 July 2006/ Returned for modification 6 August 2006/ Accepted 25 September 2006

Two yeast strains, strains XH 1026 and XH 1164, isolated from the sputum of an intensive care unit patient with acute pneumonia, were originally identified as Candida albicans and C. tropicalis, respectively. Sequence analysis of the 26S rRNA gene D1/D2 domain and the internal transcribed spacer (ITS) region indicated that the two strains represent a novel yeast species closely related to C. rogusa. The name Candida pseudorugosa sp. nov. is therefore proposed (type strain, AS 2.3107 [CBS 10433]). The new species is able to grow at 42°C and is resistant or insusceptible to amphotericin B (MIC, 2 µg/ml), caspofungin (MIC, 64 µg/ml), itraconazole (MIC, 1 µg/ml), and nystatin (MIC, 16 µg/ml); dose-dependent susceptible to fluconazole (MIC, 16 µg/ml); and susceptible to flucytosine (MIC, 0.125 µg/ml) and voriconazole (MIC, 0.125 to 0.25 µg/ml). The code for C. pseudorugosa sp. nov. provided by the API 20C AUX system is identical to that for C. rugosa. The colonies of the new species on CHROMagar Candida appear blue-green, similar to those of C. albicans. In addition to the molecular method based on D1/D2 domain or ITS region sequencing, use of the combination of the API system and CHROMagar Candida is helpful for the correct identification of C. pseudorugosa sp. nov.


* Corresponding author. Mailing address: Systematic Mycology and Lichenology Laboratory, Institute of Microbiology, Chinese Academy of Sciences, P.O. Box 2714, Beijing 100080, China. Phone: 86 10 62626752. Fax: 86 10 62626752. E-mail: baify{at}im.ac.cn.

{triangledown} Published ahead of print on 4 October 2006.


Journal of Clinical Microbiology, December 2006, p. 4486-4490, Vol. 44, No. 12
0095-1137/06/$08.00+0     doi:10.1128/JCM.01391-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.